Clinical Trials Directory

Trials / Unknown

UnknownNCT01998334

Continuous Blood Purification for Regulation of Early Inflammatory Response In Severe Acute Pancreatitis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Systemic Inflammatory response syndrome(SIRS) is common in patients with severe acute pancreatitis (SAP) in early stage. Continuous Blood Purification (CBP), especially Continuous Veno-Venous Hemofiltration(CVVH) is proved to have an important role in SAP patients to control SIRS. But the detail treatment for this is controversial. In this study, the investigators aim to evaluate the different effects of three kinds of treatment protocols which is CVVH 6h,continuous venovenous hemodiafiltration(CVVHDF) 6h,CVVH 10h for first three days in SAP patients. Compare the vital sign, SIRS parameters, and others between these three groups. This study will try to find a better way for CBP in patients with SAP

Detailed description

Condition Severe Acute Pancreatitis Intervention CVVH 6 hours for first three days CVVH 10 hours for first three days CVVHDF 6 hours for first three days All therapeutic volume is 45ml/kg.h, Device: Braxter HF 1200

Conditions

Interventions

TypeNameDescription
OTHERCVVH 6hCVVH 6h for first three days
OTHERCVVH 10hCVVH 10h for first three days
OTHERCVVHDF 6hCVVHDF 6h for first three days

Timeline

Start date
2012-07-01
Primary completion
2015-12-01
Completion
2016-12-01
First posted
2013-11-28
Last updated
2013-11-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01998334. Inclusion in this directory is not an endorsement.